Clinical features of Moyamoya disease in the United States

被引:226
作者
Chiu, D
Shedden, P
Bratina, P
Grotta, JC
机构
[1] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Neurol, Houston, TX 77225 USA
[3] Univ Texas, Hlth Sci Ctr, Greater Houston Neurosurg Ctr, Houston, TX 77225 USA
关键词
moyamoya disease; stroke; ischemic; intraventricular hemorrhage; epidemiology;
D O I
10.1161/01.STR.29.7.1347
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-We report the clinical features and longitudinal outcome of the largest cohort of patients with moyamoya disease described from a single institution in the western hemisphere. Moyamoya disease in Asia usually presents with ischemic stroke in children and intracranial hemorrhage in adults. Methods-Our study population included all patients with moyamoya disease evaluated at a university hospital in Houston, Texas from 1985 through 1995 (n=35), We used Kaplan-Meier methods to estimate individual and hemispheric stroke risk by treatment status (medical versus surgical). Predictors of neurological outcome were assessed. Results-The ethnic background of our patients was representative of the general population in Texas. The mean age at diagnosis was 32 years (range, 6 to 59 years). Ischemic stroke or transient ischemic attack was the predominant initial symptom in both adults and children. Of the 6 patients with intracranial hemorrhage, 5 had an intraventricular site of hemorrhage, The crude stroke recurrence rate was 10.3% per year in 116 patient-years of follow-up. Twenty patients underwent surgical revascularization, the most common procedure being encephaloduroarteriosynangiosis. The fi-year risk of ipsilateral stroke after synangiosis was 15%, compared with 20% for medical treatment and 22% overall for surgery. Conclusions-Our observations indicate that moyamoya disease may have a different clinical expression in the United States than in Asia, and may demonstrate a trend toward a lower stroke recurrence rate and better functional outcome after synangiosis.
引用
收藏
页码:1347 / 1351
页数:5
相关论文
共 63 条
[1]  
Abboud MR, 1996, BONE MARROW TRANSPL, V17, P405
[2]  
ADELSON PD, 1995, PEDIATR NEUROSURG, V23, P26
[3]   MOYAMOYA DISEASE IN PREGNANCY - A CASE-REPORT [J].
AMINHANJANI, S ;
KUHN, M ;
SLOANE, N ;
CHATWANI, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (02) :395-396
[4]  
ASFORA WT, 1993, AM J NEURORADIOL, V14, P29
[5]   Ocular ischemic syndrome in a child with moyamoya disease and neurofibromatosis [J].
Barrall, JL ;
Summers, CG .
SURVEY OF OPHTHALMOLOGY, 1996, 40 (06) :500-504
[6]   HEMIPLEGIC MIGRAINE AND MOYAMOYA DISEASE [J].
BERNSTEIN, AL .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (07) :718-719
[7]   Moyamoya and Down syndrome - Clinical and radiological features [J].
Cramer, SC ;
Robertson, RL ;
Dooling, EC ;
Scott, RM .
STROKE, 1996, 27 (11) :2131-2135
[8]   GENERAL-CASE OF THE DAY - MOYAMOYA SYNDROME IN A CHILD WITH SICKLE-CELL DISEASE [J].
DREW, JM ;
SCOTT, JA ;
CHUA, GT .
RADIOGRAPHICS, 1993, 13 (02) :483-484
[9]   SERIAL SPECT IMAGING IN MOYAMOYA USING I-123 IMP - A METHOD OF NONINVASIVE EVALUATION AND FOLLOW-UP [J].
FEOLE, JB ;
ALI, A ;
FORDHAM, EW ;
HUCKMAN, M ;
SHENKER, DM .
CLINICAL NUCLEAR MEDICINE, 1993, 18 (01) :43-45
[10]  
FUKUSHIMA T, 1997, PRIMER CEREBROVASCUL, P586